GIANT BIOGENE News

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024

May 3 04:33 ET

GIANT BIOGENE: FORM OF PROXY FOR USE AT 2023 ANNUAL GENERAL MEETING TO BE HELD ON 13 JUNE 2024

Apr 29 09:39 ET

GIANT BIOGENE: 2023 Environmental, Social and Governance (ESG) Report

Apr 29 09:37 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024

Apr 3 04:32 ET

GIANT BIOGENE: PROPOSED ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

Mar 25 10:01 ET

GIANT BIOGENE: Special Dividend for the Year Ended 31 December 2023

Mar 25 10:00 ET

GIANT BIOGENE: Final Dividend for the Year Ended 31 December 2023

Mar 25 10:00 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024

Mar 4 03:32 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024

Feb 2 03:59 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023

Jan 3 03:37 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2023

Dec 4, 2023 03:30 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2023

Nov 3, 2023 04:38 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2023

Oct 4, 2023 04:48 ET

GIANT BIOGENE: List of Directors and their Roles and Functions

Oct 3, 2023 04:39 ET

GIANT BIOGENE: RESIGNATION OF NON-EXECUTIVE DIRECTOR APPOINTMENT OF EXECUTIVE DIRECTORS AND SENIOR MANAGEMENT

Oct 3, 2023 04:38 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2023

Sep 4, 2023 04:43 ET

GIANT BIOGENE: REMUNERATION COMMITTEE - TERMS OF REFERENCE

Aug 28, 2023 06:21 ET

GIANT BIOGENE: CHANGE OF JOINT COMPANY SECRETARY CHANGE OF AUTHORISED REPRESENTATIVE AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES

Aug 28, 2023 06:20 ET

GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2023

Aug 2, 2023 04:38 ET

GIANT BIOGENE: FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING TO BE HELD ON AUGUST 17, 2023

Jul 31, 2023 00:14 ET